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Abstract: The need for new compounds active against malaria parasites is made more 
urgent by the rapid spread of drug-resistance to available antimalarial drugs. The crude 
methanol extract of Piper betle leaves (50–400 mg/kg) was investigated for its antimalarial 
activity against Plasmodium berghei (NK65) during early and established infections. The 
phytochemical and antioxidant potentials of the crude extract were evaluated to elucidate 
the possibilities of its antimalarial effects. The safety of the extract was also investigated in 
ICR mice of both sexes by the acute oral toxicity limit test. The leaf extract demonstrated 
significant (P < 0.05) schizonticidal activity in all three antimalarial evaluation models. 
Phytochemical screening showed that the leaf extract contains some vital antiplasmodial 
chemical constituents. The extract also exhibited a potent ability to scavenge the free 
radicals. The results of acute toxicity showed that the methanol extract of Piper betle leaves 
is toxicologically safe by oral administration. The results suggest that the Malaysian folklorical 
medicinal application of the extract of Piper betle leaf has a pharmacological basis. 
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1. Introduction 
Malaria, a tropical blood-borne protozoan disease caused by parasites of the genus Plasmodium, is 
one of the most important infectious diseases in the World. Nowadays, anti-malarial drug resistance 
has become one of the most important challenges to malaria control efforts [1]. Drug resistance is 
responsible for the spread of malaria to new areas, the recurrence of malaria in areas where the disease 
had been eradicated and plays an important role in the occurrence and severity of epidemics in some 
parts of the World [2]. Considering this growing problem, there is a broad consensus as to the need to 
develop new anti-malarial drugs which can cope with the spread of drug resistant malarial parasites 
[3,4]. The ethnomedical approach to the search for new anti-malarial drugs from plant sources has 
proved to be more predictive, where the most important modern anti-malarial drugs are derived from 
the medicinal plants known to have ethnomedical standing [5-8].  
Piper betle Linn is a liana belonging to the Piperaceae family. It is cultivated in most of South and 
Southeast Asia and valued both as a mild stimulant and for its medicinal properties. In Peninsular 
Malaysia, the leaves of Piper betle are also used by the rural population as an antimalarial remedy [9]. 
The leaves are chewed alone or with other plant materials. Recently, the leaves have been reported to 
exhibit many pharmacological effects including anti-bacterial [10], anti-leishmanial [11], anti-filarial 
[12] and anti-fungal [13] properties. This study, therefore, aims to find out if Piper betle leaves possess 
in vivo anti-malarial effects against the laboratory malaria model, Plasmodium berghei. 
2. Results and Discussion 
2.1. Phytochemical screening 
Phytochemical screening of the methanol extract of Piper betle leaves revealed that the leaf extract 
contains alkaloids, terpenes, anthraquinones, flavonoids, tannins, saponins and steroids. Phytochemical 
compounds such as alkaloids are commonly implicated in the antiplasmodial activity of many plants 
[14-17]. Terpenes or terpenoids have been identified as active antiprotozal and antimalarial agents in 
many pharmacological studies [18-21]. Flavonoids are the other forms of Piper betle phenolic 
structures. Flavonoids revealed significant anti-parasitic activities against different parasite strains of 
malaria, trypanosome and leishmania [22-24]. Derivatives of 9,10-anthraquinone include many 
important drugs including antimalarials like rufigallol [25]. These chemical compounds which were 
found in this extract may be acting singly or in synergy with one another to exert the observed 
antiplasmodial activity of Piper betle.  
2.2. Antioxidant capacity 
Investigation on the antioxidant activity of the extract against 1,1-diphenyl-2-picrylhydrazyl 
radicals (DPPH) showed that it exhibited a strong radical scavenging capacity, comparable to that of 
controls. At a concentration of 12.5 µg/mL, the scavenging activity of the methanol extract of the 
leaves reached 82.56 ± 1.50 %, while at the same concentration, those of the ascorbic and gallic acids 
controls were 72.25 ± 2.44 and 73.03 ± 2.27 %, respectively (Figure 1). The potent antioxidant 
capacity exhibited by the Piper betle leaves may be due to the phenolic compounds in this extract, 
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such as chavicol, chavibetol, chavibetol acetate and eugenol [26-28]. The antioxidant effect of the 
Piper betle leaf extract may represent another mechanism that contributes to its anti-malarial activity. 
Piper betle leaf extract decreases nitric oxide (NO) production in macrophages [29]. According to 
Daubener [30], the inhibition of NO starves the parasite of an essential amino acid, leading to its death 
by increasing tryptophan degradation through indolamine deoxygenase induction in human peritoneal 
macrophages.  
Figure 1. DPPH radical scavenging activity of methanol extract of Piper betle leaves. 
Absorbance values represent means of triplicate tests of the different concentrations analyzed. 
 
2.3. Median lethal dose 
No deaths occurred during the observation period. Some symptoms were observed 1 hour following 
administration of the extract. Ataxia and piloerection were noted in males and females; all of which 
resolved by 3 hours after administration. No abnormal general symptoms were observed in the extract 
treated groups. All animals gained body weight at the end of the 14-day observation period. 
Administration of the leaf extract at 5,000 mg/kg had no effect on the necropsy findings. 
Histopathological lesions were not observed in any of the main organs of the mice (Figure 2).  
Based on these results the median lethal dose (LD50) of the methanol extract of Piper betle leaf after 
single oral administration in male and female ICR mice was found to be greater than 5,000 mg/kg 
body weight. The LD50 value of more than 5,000 mg/kg showed that the extract is practically safe 
[31,32]. 
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Figure 2. Photomicrographs of the sections of the liver × 200, lung stroma × 200, kidney × 
200 and heart × 100 showing normal features in mice treated with 5,000 mg/kg of 
methanol extract of Piper betle leaves. 
 
2.4. In vivo antimalarial activity 
The leaf extract demonstrated significant (P < 0.05) schizonticidal activity in the all three models of 
the antimalarial evaluations. The suppression of parasitaemia by chloroquine at 20 mg/kg/day was in 
agreement with a previous study by Muregi et al. [33]. 
2.4.1. Suppressive anti-malarial activity 
The in vivo antiplasmodial activity of four different doses (50, 100, 200, and 400 mg/kg) of the 
methanol extract of Piper betle leaves administrated orally showed a dose-dependent 
chemosuppressive activity which ranged between 36.47% to 82.31 % in all groups of mice (Table 1). 
A considerably high degree of chemosuppression was shown by the 200 and 400 mg/kg doses which 
significantly decreased the parasitaemia of the infected mice when compared to control (P < 0.01). 
Table 1. Effects of methanol extract of Piper betle on early malaria infection. 
 Extract/drug Dose % Parasitaemia %Chemo-suppression Significance
Control (dist. water) 0.2 mL 5.10 ± 0.33     
Piper betle Leaf extract 50 mg/kg 3.24 ± 0.82 36.47 ns 
  100 mg/kg 2.40 ± 0.68 52.94 P < 0.05 
  200 mg/kg 1.50 ± 0.63 70.51 P < 0.01 
  400 mg/kg 0.90 ± 0.33 82.31 P < 0.01 
Chloroquine 20 mg/kg 0.00 100   
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2.4.2. Curative anti-malarial activity 
The results indicated that the methanol extract of Piper betle leaves exhibited dose-dependent 
chemosuppression in parasitaemia. This curative chemosuppression of the treated groups was 
statistically significant (P < 0.05) when compared to the control. The control group showed daily 
increases in parasitaemia reaching 12.8 % on the seventh day of infection (Figure 3). The 
chemosuppression effects for the treated groups on the sixth day of infection were 37.50, 45.83, 66.46 
and 70.63 for 50, 100, 200 and 400 mg/kg, respectively (Table 2). These treated groups (50 to  
400 mg/kg) of mice also had longer survival times which ranged between 14.40 ± 0.93 days and 19.00 
± 1.22 days as compared to the control with 13.6 ± 0.82 days. The chloroquine-treated group had a 
mean survival time of 27.20 ± 2.33 days (Table 3). 
Table 2. Activity of Piper betle on established malaria infection. 
 Extract/drug Dose % Parasitaemia %Chemo-suppression Significance
Control (dist. water) 0.2 mL 9.60 ± 0.93   
Piper betle Leaf extract 50 mg/kg 6.00 ± 0.84 37.50 P < 0.05 
 100 mg/kg 5.20 ± 0.92 45.83 P < 0.05 
 200 mg/kg 3.22 ± 0.95 66.46 P < 0.001 
 400 mg/kg 2.82 ± 0.84 70.63 P < 0.05 
Chloroquine 20 mg/kg 00 100   
Figure 3. Comparison of parasitaemia chemosuppression of the extract-treated groups and 
control from D3 until D7 after infection. 
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Table 3. Mean survival period of mice treated with Piper betle in established malaria infection. 
Drug/extract Dose Survival time (days)  Significance 
Control (dist. water) 0.2 mL 13.60 ± 0.51  
Piper betle Leaf extract 50 mg/kg 14.40 ± 0.93 ns 
 100 mg/kg 15.20 ± 1.16 ns 
 200 mg/kg 17.20 ± 1.56 ns 
 400 mg/kg 19.00 ± 1.22 P < 0.01 
Chloroquine 20 mg/kg 27.20 ± 2.33 P < 0.001 
2.4.3. Prophylactic anti-malarial activity 
The methanol extract of Piper betle exerted a dose-dependent prophylactic activity at the different 
doses employed resulting in significant (P < 0.05) reduction of parasitaemia in extract treated groups 
when compared to control. It exerted 19.57, 34.78, 52.17 and 70.88% chemosuppressions at doses of 
50, 100, 200 and 400 mg/kg, respectively. The chemosuppression shown by the highest dose of the 
extract (400 mg/kg) was comparable to that of the standard drug, pyrimethamine with 
chemosuppression of 73.04% (Table 4). 
Table 4. Effect of the methanol extract of Piper betle on residual malaria infection. 
Drug/extract Dose % Parasitaemia %Chemo-suppression Significance
Control (dist. water) 0.2 mL 4.60 ± 0.51     
Piper betle Leaf extract 50 mg/kg 3.70 ± 0.30 19.57 ns 
  100 mg/kg 3.00 ± 1.34 34.78 ns 
  200 mg/kg 2.20 ± 0.37 52.17 P < 0.05 
  400 mg/kg 1.34 ± 0.41 70.88 P < 0.001 
Pyrimethamine 1.2 mg/kg 1.24 ± 0.47 73.04 P < 0.05 
3. Experimental 
3.1. Plant materials  
The plant part (leaves) of Piper betle was selected based on an ethnobotanical survey conducted by 
the Department of Parasitology, Faculty of Medicine, University of Malaya, in two malaria endemic 
communities, forest-aboriginal and rural communities, in the Lipis district of Pahang state, Peninsular 
Malaysia [9]. The plant has been recorded as a curative and prophylactic antimalarial remedy by the 
two communities. The voucher specimen was collected and identified by the University of Malaya 
Herbarium (KLU) and deposited under the reference number KLU 046620. 
3.2. Preparation of plant extract  
The leaves of Piper betle were dried in a hot air oven at 40 °C and milled. Five hundred grams of 
the powdered leaves was soaked with absolute methanol (3.5 L, Merck, Germany) for 72 h. The 
extracts were concentrated in vacuo to dryness at 40 °C using a rotary evaporator. The percentage yield 
was 8.69%. The dry extract was stored in a refrigerator at 4 °C until used. 
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3.3. Animals 
The animals (ICR mice), both male (27 ± 2 g) and female (22 ± 2 g), 6–7 weeks old which were 
used for these experiments were obtained from the Laboratory Animal Centre of the Faculty of 
Medicine, University of Malaya. The mice were housed in standard conditions and were maintained on 
a standard pelleted feed and water ad libitum. Permission and approval for animal studies were 
obtained from the Animal Ethics Committee of the Faculty of Medicine, University of Malaya dated 
05 June 2009 (Ref. No. PAR/05/6/2009/AHAA-R). 
3.4. Phytochemical screening 
The chemical constituents of the leaf extract were tested for the presence of alkaloids, 
anthraquinones, terpenoids, flavonoids, tannins, steroids, saponins and glycosides using Dragendorff’s 
reagent, sulphuric acid-chloroform layer test, Salkowski’s test, ammonium test, lead sub-acetate 
reagent, Salkowski’s test, frothing test and Fehling’s reagent standard procedures, respectively [34,35].  
3.5. DPPH radical scavenging activity  
The antioxidant capacity of the extract was determined photometrically through its scavenging 
activity against the stable artificial free radical 1,1-diphenyl-2-picrylhydrazyl (DPPH), using the 
method of Gerhauser et al. [36]. In brief, DPPH (195 μM) was added to different concentrations of the 
extract (5 μL) in a 96-well microplate, and incubated for 3 hours and read at 20-min intervals. The 
bleaching of DPPH was observed at an absorbance of 515 nm. Ascorbic acid and gallic acid were used 
for comparison. The free radical-scavenging activity was expressed as the percentage of scavenging of 
the DPPH by the extract and was calculated as follows: 
DPPH radical scavenging activity (%) = {[Ab-Aa]/Ab} × 100 
where Ab is the absorption of the blank sample, and Aa is the absorption of the sample. Each test was 
carried out three times in quadruplicate and the mean was calculated. The DPPH % was presented as 
μg /mL of concentration. 
3.6. Median lethal dose 
Acute oral toxicity of the methanol extract of Piper betle leaves was studied according to the OECD 
guideline No 423 “Acute oral toxicity – acute toxic class method” [37]. A limit test was performed; 
one female and one male ICR mouse was administrated at 5,000 mg/kg. Since these mice survived, 
four additional mice were sequentially dosed at approximately 48 to 72-hour intervals. A total of five 
female and five male mice were tested. The mice were fasted overnight prior to administration and 
returned to feeding 3 hours later. On the day of extract administration, all the mice were observed for 
mortality and signs of toxicity at 1, 3 and 4 hours following administration and thereafter they were 
observed twice a day for 14 days. Body weights of the mice were recorded on study days -1, 0 
(initiation), 7 and 14 (termination). All experimental mice were sacrificed at the end of the observation 
period and subjected to complete gross necropsy and histopathological study. 
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3.7. Parasite inoculation 
Donor mouse blood infected with the P. berghei was used for inoculum preparation. The desired 
blood volume was drawn from the donor mouse by heart puncture and diluted serially in Alsever’s 
solution. The final suspension would contain about 1 × 106 infected RBC’s in every 0.2 mL 
suspension. This 0.2 mL suspension was injected into mice intraperitoneally to initiate infection [38]. 
The inoculated animals were then randomized into five mice per cage and maintained in the Animal 
Room, Department of Parasitology, Faculty of Medicine, University of Malaya, in accordance with the 
internationally accepted principles for laboratory animals use and care. 
3.8. In vivo antimalarial assays 
A series of in vivo antimalarial assays were carried out to evaluate the in vivo anti-malarial activities 
of the methanolic extract of Piper betle leaves at 50, 100, 200 and 400 mg/kg doses as compared to 
control groups treated with distilled water (containing 10% DMSO, the solvent of the test extracts) and 
reference groups treated with standard drugs (chloroquine 20 mg/kg or pyrimethamine 1.2 mg/kg). 
Malaria infection was first established in female mice by the intraperitoneal (i.p.) administration of 
donor female ICR mouse blood containing about 1 × 106 parasites. The percentage parasitaemia was 
determined by counting the parasitized red blood cells out of 9000 RBC’s in random fields of the 
microscope: 
%Parasitaemia = ቂ N୭.୭୤ ୮ୟ୰ୟୱ୧୲୧୸ୣୢ RBC
T୭୲ୟ୪ ୬୭.୭୤ RBC ୡ୭୳୬୲ୣୢ
ቃ 100 
Average percentage chemosuppression was calculated as: 
100 ൤
A െ B
A
൨ 
where A is the mean percentage parasitaemia in the negative control group and B is the mean 
percentage parasitaemia in the test group. 
3.8.1. 4-day suppressive activity (early malaria infection) 
Suppressive activity of the extract was assessed using the method described by Peters and Robinson 
[39]. Thirty female ICR mice were first inoculated intraperitoneally with 0.2 mL suspension containing 
1 × 106 P. berghei on the first day (D0). After 2–4 hours post-infection, the experimental groups were 
treated orally with 50, 100, 200 and 400 mg/kg/day doses of the extract. The reference drug group was 
treated with chloroquine (20 mg/kg) and the control group received distilled water 0.2 mL/kg. All the 
treatments were repeated for the next three days (D1 to D3). On the fifth day (D4), thin blood smears 
were prepared from each mouse and stained with Giemsa’s stain. 
3.8.2. Curative activity (established malaria infection) 
Thirty mice were selected and inoculum of 0.2 mL (1 × 106 P. berghei) was given to each mouse 
(i.p.). The mice were then regrouped into six groups of five mice each. Seventy-two hours later, the 
experimental groups were treated orally with 50, 100, 200 and 400 mg/kg/day doses of the extract. The 
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reference drug group was treated with chloroquine (20 mg/kg) and the control group received distilled 
water 0.2 mL. The treatments were continued daily until D7. Thin blood smears were collected daily 
from tail blood, stained with Giemsa’s stain and examined microscopically for determination of 
parasitaemia. On the sixth day of the infection, the mean percentage suppression of parasitaemia was 
calculated according to the procedure described by Ryley and Peters [40] and Saidu et al. [41]. The 
mean survival time (days) for each group was determined over a period of 30 days post-infection. 
3.8.3. Prophylactic activity (residual malaria infection) 
The prophylactic activity of the extracts was assessed using the method described by Peters [42]. 
The experimental mice were randomly divided into six groups of five mice each. The mice were 
administered orally with 50, 100, 200 and 400 mg/kg/day of the extract, pyrimethamine 1.2 mg/kg/day 
was administered to the reference drug group, and distilled water 0.2 mL to the control group. The 
treatment was given for 3 consecutive days (D0–D2). On the fourth day (D3), all mice were infected 
with 1 × 106 P. berghei and kept for the next 3 days. On D7, blood smears were prepared from the tail 
blood. The percentage of suppression of parasitaemia was then calculated. 
3.9. Statistical analysis  
All data were expressed as mean ± S.D. and S.E.M. of triplicate parallel measurements. Statistical 
analysis was performed using Students’ t-test and ANOVA (one- or two-way). Differences between 
means at 1 and 5% level (P ≤ 0.01 and 0.05) were considered significant. 
4. Conclusions 
The leaf extract of Piper betle demonstrated significant (P < 0.05) schizonticidal activity in all the 
three models of the antimalarial evaluations. The results of this study provide a basis for further studies 
on the plant. These include the isolation and characterization of the bioactive principles with the 
ultimate objective of finding novel antimalarial compounds which can be used in the fight against drug 
resistant malaria. This study also suggests that the Malaysian folkloric medicinal application of the 
extract of Piper betle leaves has a pharmacological basis. 
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